DESCRIPTION
- Manufacturer: Merck
- Substance: Sitagliptin
- Strength: 28 Film Tablets, 100 mg/tab
- Availability: IN STOCK
JANUVIA belongs to a new breakthrough class of prescription medications called dipeptidyl peptidase-4 (DPP-4) inhibitors that improves blood sugar control in patients with type 2 diabetes. JANUVIA enhances a natural body system called the incretin system, which helps to regulate glucose by affecting the beta cells and alpha cells in the pancreas. Through DPP-4 inhibition, JANUVIA works only when blood sugar is elevated to address diminished insulin due to beta-cell dysfunction and uncontrolled production of glucose by the liver due to alpha-cell and beta-cell dysfunction.
JANUVIA is only part of a complete program of treatment that also includes diet, exercise, weight control, and possibly other medications. It is important to use this medication regularly to get the most benefit.
